awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35198335-76023CD8-BC9C-4C59-A1D2-63C09231B791
Q35198335-76023CD8-BC9C-4C59-A1D2-63C09231B791
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35198335-76023CD8-BC9C-4C59-A1D2-63C09231B791
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer
P2860
Q35198335-76023CD8-BC9C-4C59-A1D2-63C09231B791
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35198335-76023CD8-BC9C-4C59-A1D2-63C09231B791
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00e699d282a1b8decf91e0997521af03e2127752
P2860
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic color